The Amplify Seymour Cannabis ETF (CNBS) is an actively managed exchange-traded fund that invests at least 80% of assets in U.S. companies deriving half or more of revenue from the cannabis and hemp ecosystem, using total return swaps to access U.S. multi-state operators (MSOs). Because it is an ETF rather than an individual stock, there is no published analyst price-target consensus, as multiple data providers confirm.
The $30 objective therefore comes from public discussion rather than an analyst aggregate. It sits near the $29.50 midpoint of independent valuation and naive-forecast models widely cited in market commentary, and it represents a round-number psychological level that is well within the fund's recent 52-week high of about $43.94. In other words, $30 is a realistic technical and valuation milestone being discussed publicly, not a manufactured headline figure.
As of late October 2026, CNBS traded near $23.60, down sharply from its post-rescheduling surge but well above its 52-week low of roughly $18.43. A move to $30 implies about 27% upside, which qualifies as a substantial rally for a concentrated thematic fund.
The path would likely depend on U.S. operators converting Schedule III tax relief into reported free cash flow. The fund's blended P/E (price-to-earnings) ratio has been cited around 12.7, reflecting a portfolio still recovering from a multi-year drawdown. If earnings revisions turn positive and institutional capital returns to the sector, the gap toward $30 could narrow; if regulatory momentum stalls, the fund could remain range-bound or retest lower support.
CNBS has carved out a durable range between the $18.43 support zone and the $43.94 peak. The $30 level sits roughly midway, acting as a psychological resistance that the fund last traded above during its earlier 2026 surge. A sustained move above $30 would require clearing that resistance, while a loss of the low-$20s could signal a retest of the lower band.
Public price objectives for this ETF typically reflect a 6-to-12-month forward view rather than a firm analyst horizon. Key items to watch include the progress of DEA administrative hearings, any IRS guidance on when 280E relief takes effect, the status of the SAFE Banking Act, quarterly earnings from the largest MSO holdings, and any changes in fund flows or swap positions disclosed in monthly reports.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. For a volatile thematic fund like CNBS, these signals can help traders identify shifting momentum and changing trends more efficiently than manual chart review. Traders can use the tool to discover opportunities, track existing positions, and stay ahead of inflection points. Explore the signals to see how AI-driven analysis can support your market monitoring.
Can CNBS reach $30? The objective is grounded in public discussion around a psychological round-number level near independent valuation estimates, not in a formal analyst consensus. From a price near $23.60, it would require a substantial 27% gain. Support rests on the structural shift from Schedule III rescheduling and 280E relief, while concentration, swap complexity, and regulatory risk remain the principal obstacles. With no analyst target range to weigh, investors should track the regulatory timeline, operator earnings, and technical behavior around the $30 level before drawing conclusions.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, CNBS has been closely correlated with MSOS. These tickers have moved in lockstep 99% of the time. This A.I.-generated data suggests there is a high statistical probability that if CNBS jumps, then MSOS could also see price increases.
| Ticker / NAME | Correlation To CNBS | 1D Price Change % | ||
|---|---|---|---|---|
| CNBS | 100% | +2.43% | ||
| MSOS - CNBS | 99% Closely correlated | +2.66% | ||
| JETS - CNBS | 34% Loosely correlated | +1.27% | ||
| BOTZ - CNBS | 21% Poorly correlated | +1.34% | ||
| KOMP - CNBS | 21% Poorly correlated | +2.32% | ||
| NUKZ - CNBS | 18% Poorly correlated | +2.61% | ||
More | ||||